The test consists of a small device that requires only 10 microlitres of patient serum or
plasma, or 20 microlitres of whole blood, to be loaded into a receptacle, alongside an
included buffer, which then mixes with viral S protein fragments and migrates along
the device to an area of immobilized capture antibodies. If virus specific IgG or IgM is
present, conjugates are formed, which show up as a distinctive red band on the
device.
Clinical validation studies have been completed by the manufacturer according to
Administrative Measures for Registration of In-vitro Diagnostic Reagents.
They will have to test it on infected people here, this is a huge gamble, it sounds very much like the shonky kits that screwed over Spain to me
- Forums
- ASX - By Stock
- Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
The test consists of a small device that requires only 10...
-
- There are more pages in this discussion • 1,236 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
-0.001(12.5%) |
Mkt cap ! $3.229M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $91 | 13K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 620225 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 615000 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 620225 | 0.007 |
3 | 1016527 | 0.006 |
3 | 1000000 | 0.005 |
3 | 1075000 | 0.004 |
2 | 766667 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 615000 | 4 |
0.013 | 750000 | 1 |
0.015 | 340000 | 2 |
0.016 | 750000 | 2 |
0.017 | 150000 | 1 |
Last trade - 11.59am 24/06/2024 (20 minute delay) ? |
Featured News
AN1 (ASX) Chart |